The CT motion quantitation of lung lesions and its impact on PET-measured SUVs.
about
A review on segmentation of positron emission tomography images4D PET/CT as a Strategy to Reduce Respiratory Motion Artifacts in FDG-PET/CTAccelerometer-Based Method for Extracting Respiratory and Cardiac Gating Information for Dual Gating during Nuclear Medicine ImagingInfluence of rigid coregistration of PET and CT data on metabolic volumetry: a user's perspectiveRespiratory motion reduction in PET/CT using abdominal compression for lung cancer patients.Effects of respiration-averaged computed tomography on positron emission tomography/computed tomography quantification and its potential impact on gross tumor volume delineation.The impact of respiratory motion on tumor quantification and delineation in static PET/CT imagingAdvances in 4D radiation therapy for managing respiration: part I - 4D imaging.Quiescent period respiratory gating for PET/CT.2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.Rapid estimation of 4DCT motion-artifact severity based on 1D breathing-surrogate periodicity.Adaptation of the modified Bouc-Wen model to compensate for hysteresis in respiratory motion for the list-mode binning of cardiac SPECT and PET acquisitions: testing using MRIOptimal gating compared to 3D and 4D PET reconstruction for characterization of lung tumours.Pulmonary imaging using respiratory motion compensated simultaneous PET/MRRespiratory motion correction of PET using MR-constrained PET-PET registration.Respiration-Averaged CT for Attenuation Correction of PET Images - Impact on PET Texture Features in Non-Small Cell Lung Cancer PatientsPET/CT imaging: effect of respiratory motion on apparent myocardial uptakeThe applications of corrected standardized uptake values in the diagnosis of peripheral lung lesions.Impact of PET - CT motion correction in minimizing the gross tumor volume in non-small cell lung cancerTumor quantification in clinical positron emission tomography.Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer.Implementation of an automated respiratory amplitude gating technique for PET/CT: clinical evaluation.The clinical significance and management of lesion motion due to respiration during PET/CT scanning.Techniques for respiration-induced artifacts reductions in thoracic PET/CT.Challenges and opportunities in patient-specific, motion-managed and PET/CT-guided radiation therapy of lung cancer: review and perspective.A novel approach to assess the treatment response using Gaussian random field in PET.Attenuation correction in 4D-PET using a single-phase attenuation map and rigidity-adaptive deformable registration.Clinical respiratory motion correction software (reconstruct, register and averaged-RRA), for 18F-FDG-PET-CT: phantom validation, practical implications and patient evaluation.Respiratory motion correction in 4D-PET by simultaneous motion estimation and image reconstruction (SMEIR)The impact of audio-visual biofeedback on 4D PET images: results of a phantom studyNonrigid PET motion compensation in the lower abdomen using simultaneous tagged-MRI and PET imaging.Average CT in PET studies of colorectal cancer patients with metastasis in the liver and esophageal cancer patients.Impact of CT attenuation correction method on quantitative respiratory-correlated (4D) PET/CT imaging.Respiratory motion correction for quantitative PET/CT using all detected events with internal-external motion correlation.Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.Role of 18F-FDG PET/CT vs CT-scan in patients with pulmonary metastases previously operated on for colorectal liver metastases.Motion artifacts occurring at the lung/diaphragm interface using 4D CT attenuation correction of 4D PET scans.89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding.An account of data entry inconsistencies and their impact on positron emission tomography quantification
P2860
Q26825470-6D15CB18-EEC4-400A-8F39-19D90D5BC163Q27012900-1B8C51BE-C552-44F9-8410-77A5862E9C5EQ30433081-8658C29D-8BDA-42FB-A2A4-4D8FAC2BA0C1Q30724225-82C34912-BAD8-4E95-8CAD-91CA24AF3642Q33623848-8E41CB3F-49C1-415C-B3B3-06779E4DF9ADQ33921209-307435F4-8730-45AE-AAC7-D3201DDA8D31Q33955314-422FD955-01EB-4DAE-8B6C-5BEEC66845CDQ34129251-7DD38802-A4CA-465C-AD43-1817BAB41AB7Q34156037-5645B3FC-EC09-4349-BE57-6D0EAB834AC1Q34404416-F5BC4E55-9BAF-4598-8B75-840A9FAD5365Q34562941-775D2373-FC13-4424-A8AF-483BF78A2E88Q34564916-EBD74BB6-96AE-485B-82C4-310DE8D972ECQ34756997-2F5927B7-CE13-4C94-84D9-75A2D9FC4B8BQ35761852-A516E67D-413A-440A-B15E-FB51FAF4ECCCQ35781102-3AA92786-6C03-4A48-9D82-F14C65FB5466Q35940876-A819C079-93CC-407E-A353-76F946C3FB73Q36073074-66604DCA-BF88-4F89-A298-1D7D40EBBDDEQ36152297-12CD7608-F589-439C-BF04-3FA072C9C16FQ37052259-CB39C628-6687-4817-939A-F5EF2B78BC6CQ37342658-C4893D18-3D2F-4B71-B266-EC3ED7AA3FC2Q37482604-7F5B35DD-038C-4F6F-8010-5C00D49C42D2Q37659389-059A4E5F-64F1-42A7-8348-7255CA1D3D54Q37971475-CECA9CF4-5231-4967-88FE-4493158C5131Q38068870-C799A286-3AE1-48C6-A9E3-562EBD725F89Q38078108-FFEC65B6-DEE9-4AA0-A670-0DFE4E6F8624Q38912360-A1E4A63E-4975-4004-8C4F-E01A07437E81Q39093090-9941A35D-FB6A-4EB8-B141-B8C8006E6F0CQ39114284-21DB8A1C-69E8-4354-88B8-3AAE7DE8A80AQ39626158-E164C8BF-6661-4F6D-BA05-C92469688F3DQ41247414-0FC00D9D-F4EE-44B7-93AD-B5B0B570E5B8Q41814241-39750E68-0AD8-4623-9803-F41809C543FCQ41856102-298B382D-495D-45DE-AA76-6052DF05F39CQ42355410-BDA904E1-0161-4A9D-A4AC-F2EDF989147AQ42745746-64067C6F-4442-4775-A4E4-46B8154EF850Q45065502-E5D97FA9-4386-4349-8FAC-A29B748E31B6Q50072673-DBD1FED7-8D00-49ED-889D-67625E7FF5FFQ51496759-E663ADD6-9F69-41C9-A116-5EBFD85099B3Q55362101-A7A0F857-BD23-44B3-9162-A0D73750EDDFQ58739579-4D55FBB0-78E8-41BA-BDCB-1B45BCBBB00E
P2860
The CT motion quantitation of lung lesions and its impact on PET-measured SUVs.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The CT motion quantitation of lung lesions and its impact on PET-measured SUVs.
@en
The CT motion quantitation of lung lesions and its impact on PET-measured SUVs.
@nl
type
label
The CT motion quantitation of lung lesions and its impact on PET-measured SUVs.
@en
The CT motion quantitation of lung lesions and its impact on PET-measured SUVs.
@nl
prefLabel
The CT motion quantitation of lung lesions and its impact on PET-measured SUVs.
@en
The CT motion quantitation of lung lesions and its impact on PET-measured SUVs.
@nl
P2093
P1476
The CT motion quantitation of lung lesions and its impact on PET-measured SUVs
@en
P2093
Alexander Pevsner
Ellen D Yorke
Hassan Mostafavi
Heiko Schoder
John L Humm
Jonathan B Ashman
Kenneth E Rosenzweig
Olivia D Squire
Phil Vernon
Sadek A Nehmeh
P304
P407
P577
2004-08-01T00:00:00Z